跳至主要内容
临床试验/NCT06090526
NCT06090526尚未招募不适用

Pancreatic Stone Protein as Indicator for Urinary Sepsis in Intensive Care Units

Ain Shams University0 个研究点目标入组 80 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
PSP ability to detect urinary sepsis

研究概览

简要总结

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. For clinical operationalization, organ dysfunction can be represented by an increase in the Sequential Organ Failure Assessment (SOFA) score of 2 points or more, which is associated with an in-hospital mortality greater than 10%. pancreatic stone protein has been studied as biomarker of sepsis and results suggests that it has higher diagnostic performance. The main objective of this study is to identify ability of pancreatic stone protein (PSP) as a new biomarker for diagnosis of urosepsis in Intensive Care Units comparison to other biomarkers and its role as a prognostic marker for mortality

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult ill patients at the ICU aged more than 18 years old who at risk of urosepsis.
  • Both males and females.

排除标准

  • - Age less than 18 years.
  • Patients with a clinical diagnosis of sepsis at admission.
  • Critically ill septic patients with a diagnosis other than urosepsis.
  • Critically ill patients who were diagnosed to have urosepsis outside Ain Shams university intensive care and transferred to it.
  • Malignant tumor patients.
  • Uremic patients undergoing dialysis.

结局指标

主要结局

PSP ability to detect urinary sepsis

时间窗: measurements from admission and patients will be followed until death or discharge from or for 30 days whichever occurred the ICU

time course of PSP serum levels above normal range 20-50ng/ml in absence or presence of infection.

次要结局

  • PSP ability to predict prognosis of sepsis in ICU.(measurements from admission and patients will be followed until death or discharge from or for 30 days whichever occurred the ICU)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Sayed Maamoun Ibraheem

Doctor

Ain Shams University

相似试验